| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 05/02/2008 | WO2008050726A1 Novel fused-ring aromatic compound, process for producing the same, and use thereof |
| 05/02/2008 | WO2008050600A1 Therapeutic or preventive agent for intractable disease based on oxidative stress-mediated cell death as molecular background |
| 05/02/2008 | WO2007150010A3 Cyclopropyl amine derivatives as histamin h3 receptor modulators |
| 05/02/2008 | CA2667176A1 Therapeutic agent for irritable bowel syndrome |
| 05/02/2008 | CA2647329A1 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno(2,3-d)pyrimidine |
| 05/01/2008 | US20080103230 Monomers for polyepisulfides, polythiourethanes, or acrylic esters with internal thio groups; optical lens protective coatings with a high refractive index; reacting a bis-ethylenetrithiocarbonate sulfide or bis-ethylenetrithiocarbonate with an oxirane or thiirane and tetrafluoroboric acid catalyst |
| 05/01/2008 | US20080103168 phosphodiesterase inhibitor; antiinflammatory agent; 3-thia-10-aza-phenanthrenes and iintermediates 3-(3,4-dialkoxy-phenyl)-tetrahydro-thiopyran-4-one and 3-(3,4-dialkoxy-phenyl)-1,1-dioxo-hexahydro-1-thiopyran-4-ylamine, useful for its preparation |
| 05/01/2008 | US20080103131 Therapeutically Active Thiophenepyrimidinone Compounds and Their Use |
| 05/01/2008 | US20080102068 Mitotic Kinesin Inhibitors |
| 04/30/2008 | EP1916250A1 Electronic devices comprising poly(dithienyl-benzodithiophenes) as semiconductors |
| 04/30/2008 | EP1915379A1 Olanzapine analogs and methods of use thereof |
| 04/30/2008 | EP1915378A1 Viral polymerase inhibitors |
| 04/30/2008 | EP1915150A1 Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 04/30/2008 | CN101171254A Fused thieno[2,3-B]pyridine and thiazolo[5,4-B]pyridine compounds for inhibiting KSP kinesin activity |
| 04/30/2008 | CN101171252A Tetracyclic azapyrazinoindolines as 5-HT2 ligands |
| 04/30/2008 | CN101171052A Compounds for inhibiting KSP kinesin activity |
| 04/30/2008 | CN101170161A Electronic devices |
| 04/30/2008 | CN101168544A Technique for preparing olanzapine |
| 04/30/2008 | CN100384852C Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase |
| 04/30/2008 | CN100384836C Novel cyclic amide derivatives |
| 04/29/2008 | US7365205 Diamine derivatives |
| 04/29/2008 | US7365200 4-(4-fluoro-benzyl)-5-oxo-7-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-4,5-dihydro-thieno[3,2-b]pyridine-6-carboxylic acid ethyl ester; antitumor, angiogenesis antagonist; antiinflammatoy agent; indirect inhibition of cytokines, growth factors, chemokines, and lymphokines |
| 04/29/2008 | US7365080 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/24/2008 | WO2008049047A2 Quinoline compounds |
| 04/24/2008 | WO2008047896A1 Field-effect transistor |
| 04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
| 04/24/2008 | WO2008047198A1 Therapeutic pyrazolyl thienopyridines |
| 04/24/2008 | WO2008046949A1 Method for obtaining derivatives of dichalcogenophene-tetrachalcogenofulvalene and use thereof |
| 04/24/2008 | WO2008020206A3 Fused thiophene derivatives as mek inhibitors |
| 04/24/2008 | WO2007136990A3 Prolyl hydroxylase inhibitors |
| 04/24/2008 | US20080097109 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/24/2008 | US20080097101 Reacting 2-(2-thieno)ethylamine with paraformaldehyde to form 4,5,6,7-tetrahydrothieno(3,2-c)pyridine which is then reacted with a halobenzene without isolating 2-(2-thienyl)ethyl formimine; one pot cyclization |
| 04/24/2008 | US20080096882 PDE4 (Phosphodiesterase) inhibitors; respiratory diseases, gastrointestinal diseases, inflammation the joints, skin or eyes, cancers, or diseases of the peripheral or central nervous system |
| 04/24/2008 | US20080096871 Schizophrenia, bipolar I disorder, agitation, borderline personality disorder; intramuscular sustained release formulations and depots |
| 04/24/2008 | US20080096830 9a-aza-9a-Homoerythromycin derivatives with a dibenzo[e,h]azulene subunit; asthma, adult respiratory distress syndrome; gastrointestinal, respiratory system, autoimmune, genetic, skin, rheumatic, or smooth muscular disorders; inhibitors of tumor necrosis factor, interleukins, leukotrienes, lipoxygenase |
| 04/24/2008 | CA2666603A1 Therapeutic pyrazolyl thienopyridines and uses thereof for treating tgf.beta. mediated conditions |
| 04/24/2008 | CA2666508A1 Quinoline compounds |
| 04/23/2008 | EP1534716B1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 04/23/2008 | EP0984928B1 Heterocyclic nitrato derivatives |
| 04/23/2008 | CN101166745A Novel thienopyridine compounds, and methods of use thereof |
| 04/23/2008 | CN101166744A Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/23/2008 | CN100383144C Intermediate of olanzapine, preparation and application thereof |
| 04/22/2008 | US7361660 Chemical compounds |
| 04/17/2008 | WO2008046084A2 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2005047266A9 Aryl imidazoles and their use as anti-cancer agents |
| 04/17/2008 | US20080090978 Ligand of cyclopentadiene fused to heterocycle with atom(s) of boron, nitrogen, oxygen, aluminum, silicon, phosphorus, sulfur, gallium, germanium, arsenic, selenium, indium, tin, antimony and/or tellurium; coordination catalysts; isotatic, syndiotactic or atactic polyethylene, polypropylene or copolymer |
| 04/17/2008 | US20080090861 Cancer and fibrotic disorders such as scarring prevention; 2-(4-methyl-1-(6-methylpyridin-2-yl)-1H-pyrazol-5-yl)thieno[2,3-c]pyridine for example; activin receptor-like kinase-5 (ALK-5) inhibitors |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090858 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 04/17/2008 | US20080090834 Selective azole pde10a inhibitor compounds |
| 04/17/2008 | US20080090815 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 04/16/2008 | EP1910378A1 Hepatitis c inhibitor peptide analogs |
| 04/16/2008 | EP1910338A2 Heterotetracyclic compounds as tpo mimetics |
| 04/16/2008 | EP1910302A1 Carbonyl substituted pyrazoline compounds, their preparation and use as cb1 receptor modulators |
| 04/16/2008 | CN101163707A Thienopyridines |
| 04/16/2008 | CN101163706A Dihydrothienopyrimidines for the treatment of inflammatory diseases |
| 04/16/2008 | CN101161656A Dibenzo tetrathiafulvalene tetracarbonyl imide derivative and preparation method and uses thereof |
| 04/16/2008 | CN100381431C Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives |
| 04/15/2008 | US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/15/2008 | US7358266 Cyclopropyl and cyclobutyl epothilone analogs |
| 04/15/2008 | US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents |
| 04/10/2008 | WO2008004249A3 An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts |
| 04/10/2008 | WO2007149451B1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 04/10/2008 | WO2007132430A3 Porphyrinogen derivatives useful as explosives detection markers |
| 04/10/2008 | US20080085925 Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands |
| 04/10/2008 | US20080085239 complex with radioisotope; anticancer radiopharmaceutical; diagnosis of tumors |
| 04/09/2008 | EP1908765A1 Thienopyrimidine derivative |
| 04/09/2008 | EP1907398A1 Therapeutic agents |
| 04/09/2008 | EP1907397A1 Method of preparing clopidogrel and intermediates used therein |
| 04/09/2008 | EP1907395A1 Abca1 elevating compounds |
| 04/09/2008 | EP1907394A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 04/09/2008 | EP1907384A2 Gpcr agonists |
| 04/09/2008 | CN101160316A Thienopyrimidines useful as aurora kinase inhibitors |
| 04/09/2008 | CN100379727C Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation |
| 04/08/2008 | US7355775 Photochromic diarylethene-containing coordination compounds and the production thereof |
| 04/08/2008 | US7354949 Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia |
| 04/08/2008 | US7354905 Thrombosis therapy; anticoagulants |
| 04/03/2008 | WO2008039414A1 Process for the preparation of 4-hydroxythieno[2,3-b]pyridine-5-carbonitriles |
| 04/03/2008 | WO2008038251A2 3-aza-bicyclo[3.1.0]hexane derivatives |
| 04/03/2008 | WO2008038175A2 Dithiolopyrrolones compounds and their therapeutic applications |
| 04/03/2008 | CA2664239A1 Process for the preparation of 4-hydroxythieno[2,3-b]pyridine-5-carbonitriles |
| 04/03/2008 | CA2662612A1 3-aza-bicyclo[3.1.0]hexane derivatives |
| 04/02/2008 | EP1905773A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| 04/02/2008 | EP1904504A2 Inhibitors of vegf receptor and hgf receptor signaling |
| 04/02/2008 | EP1904503A1 1h-thieno[2,3-c]-pyrazole compounds useful as kinase inhibitors |
| 04/02/2008 | CN101153042A Thienopyrimidine compound and use of the same |
| 04/02/2008 | CN100378106C Process and intermediates for the preparation of the thienopyrrole derivatives |
| 04/02/2008 | CN100378095C Substituted indoles as alpha-1 agonists |
| 03/27/2008 | WO2008035629A1 Pyrazolopyrimidine derivative |
| 03/27/2008 | WO2008034912A2 Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof |
| 03/27/2008 | WO2007136668A9 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 03/27/2008 | WO2007132179A3 Therapeutics comprising pyridinium derivatives |
| 03/27/2008 | WO2007117381A9 2 -aminopyridine analogs as glucokinase activators |
| 03/27/2008 | US20080076935 Organic semiconductor compound, organic semiconductor thin film, organic semiconductor coating liquid, organic thin film transistor, methods for producing bis(benzo[4,5] thieno)[2,3-b:3'2'-e][1,4]dithiin and bis(benzo [4,5]thieno)[2,3-b:2'3'-e][1,4]dithiin |
| 03/27/2008 | US20080076926 Process for the preparation of 4-hydroxythieno[2,3-b]pyridine-5-carbonitriles |
| 03/27/2008 | US20080076758 1S,4S)-2-((2-(1H-indazol-4-yl)-4- morpholinothieno[3,2-d]pyrirnidin-6- yl)methyl)-5-methylsulfonyl-2,5- diaza-bicyclo[2.2.1]heptane; 2-(6-fluoropyridin-3-yl)-6-((4- methylsulfonylpiperazin-1-yl)methyl)-4- morpholinothieno[3,2-d]pyrimidine; treats cancer mediated by pik3 kinase; enzyme inhibitors |
| 03/27/2008 | US20080076137 Bioanalytic Systems and Methods |
| 03/26/2008 | EP1903046A1 New clopidogrel salt and its crystalline forms |